Mirus Bio LLC Company Profile

09:44 EST 22nd November 2017 | BioPortfolio


News Articles [0 Results]


Drugs and Medications [0 Results]


PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

The New MIRUS System for Short-Term Sedation in Postsurgical ICU Patients.

To evaluate the feasibility and safety of the MIRUS system (Pall International, Sarl, Fribourg, Switzerland) for sedation with sevoflurane for postsurgical ICU patients and to evaluate atmospheric pol...

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Evaluation of Mirus™ for Sedation in Resuscitation

Current recommendations for the conduct of sédationanalgésie ICU encourage the use of the lightest possible sedation strategies, avoiding the administration of benzodiazepines source of ...

Sevoflurane in Subarachnoidal Haemorrhage

Feasibility and safety of short term application of sevoflurane in patients with SAH treated with aneurysm coiling or clipping in the setting of a neurointensive care unit.

Companies [2 Associated Companies listed on BioPortfolio]

Mirus Bio LLC


Mirus Bio Corporation

Mirus Bio Corporation is a biopharmaceutical company focused on discovering, developing and commercializing innovative nucleic acid based technologies and products. The company currently markets a ran...

More Information about "Mirus Bio LLC" on BioPortfolio

We have published hundreds of Mirus Bio LLC news stories on BioPortfolio along with dozens of Mirus Bio LLC Clinical Trials and PubMed Articles about Mirus Bio LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Mirus Bio LLC Companies in our database. You can also find out about relevant Mirus Bio LLC Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record